La vendita allo scoperto per PermRock Royalty Trust dà agli investitori un'idea del grado in cui gli investitori stanno scommettendo sul declino delle azioni di PermRock Royalty Trust. I dati relativi alle vendite allo scoperto vengono aggiornati ogni due settimane.

PermRock Royalty Trust (NYSE:PRT) Azioni, Report sulle vendite allo scoperto

PermRock Royalty Trust

PermRock Royalty Trust operates as a statutory trust. Its purpose is to own the Net Profits Interest, to distribute to the Trust unitholders cash that it receives in respect of the Net Profits Interest, and to perform certain administrative functions. The Net Profits Interest entitles the trust to receive 80% of the net profits from the sale of oil and natural gas production from the underlying properties of its trustor.

PORT FD GDR

Portion

Prothena Corporation plc - Ordinary Shares

Prothena Corp PLC

PureTech Health plc - American Depositary Shares

PureTech Health PLC

Petro Matad Ltd

Portage Biotech Inc

Priority Technology Holdings, Inc. - Common Stock

Priority Technology Holdings Inc

Priority Technology Holdings Inc Units Cons of 1 Sh ' 1 Wt

Priority Technology Holdings Inc Warrants (15/11/2021)

Port Inc

Pennsylvania Real Estate Investment Trust 7 3/8 % Cum Red Perp Pfd Shs Series -B-

Pennsylvania Real Estate Investment Trust 7.20% Cum Red Perp Registered Pfd Shs Series -C-

Pennsylvania Real Estate Investment Trust 6.875% Cum Red Perp Pfd Shs Series -D-

PRTS CAM PTE LTD TOKEN by PRTS CAM PTE LTD.

Precicion Trim Inc

CarParts.com Inc

PROTECT PHARMS CORP by Protect Pharmaceutical Corp

Protect Pharmaceutical Corp

Partners Value Investments LP Cum Red Pref Registered Units -A- Series -1-

Party City Holdco Inc

Procter &amp; Gamble Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PG#NYSE">PG</a>) shares are trading lower after the company reported&nbsp;first-quarter&nbsp;sales of&nbsp;$21.74 billion&nbsp;(-1% Y/Y),&nbsp;missing the analyst <a target="_blank" href="https://www.benzinga.com/pressreleases/24/10/b41399117/p-g-announces-fiscal-year-2025-first-quarter-results" rel="noreferrer noopener">consensus estimate of&nbsp;$21.91 billion</a>.
Organic sales, which exclude the impacts of foreign exchange and acquisitions and divestitures, increased&nbsp;by 2%.
Organic sales growth was driven by a 1% increase in higher pricing and a 1% rise in organic volume, excluding the effects of acquisitions and divestitures.
Sales in the Beauty segment fell&nbsp;5%, and the Baby, Feminine &amp; Family Care segment declined 2%.
Meanwhile, the Grooming segment sales sales remained flat, while Fabric &amp; Home Care grew 1% and Health Care sales increased&nbsp;2%.
Gross profit remained flat&nbsp;at $11.3 billion. The reported gross margin expanded by 10 basis points to&nbsp;52.1%, and the core gross margin was flat year-over-year.
Gains included 170 basis points from productivity savings and 30 basis points from pricing, offset by 90 basis points from higher commodity costs, 60 basis points from unfavorable mix, and 40 basis points from product reinvestments.
Operating margin expanded 30 basis points to&nbsp;26.7% while operating income for the quarter rose 1%&nbsp;to&nbsp;$5.80 billion.
Adjusted EPS of&nbsp;$1.93 <a target="_blank" href="https://www.benzinga.com/earnings" rel="noreferrer noopener">beat the analyst consensus of&nbsp;$1.90.</a>
P&amp;G held&nbsp;$12.16 billion&nbsp;in cash and equivalents as of September 30. Operating cash flow for the quarter was&nbsp;$4.3 billion.
The company returned around $4.4&nbsp;billion&nbsp;of value to shareholders via&nbsp;$2.4 billion&nbsp;in dividend payments and&nbsp;$1.9 billion&nbsp;of share repurchases.
&#8220;We remain committed to our integrated growth strategy of a focused product portfolio of daily use categories where performance drives brand choice, superiority — across product performance, packaging, brand communication, retail execution and consumer and customer value — productivity, constructive disruption and an agile and accountable organization,&#8221; said Board Chairman, President, and CEO Jon Moeller.
Outlook: P&amp;G reaffirmed FY25 guidance for all-in sales growth of&nbsp;2%&nbsp;–&nbsp;4%&nbsp;and <a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener">organic sales growth of&nbsp;3%&nbsp;–&nbsp;5%</a>.
This&nbsp;outlook equates to FY25 revenue of&nbsp;$85.72 billion&nbsp;–&nbsp;$87.40 billion&nbsp;(versus an estimate of&nbsp;$86.06 billion) and adjusted EPS of&nbsp;$6.91&nbsp;–<a target="_blank" href="https://www.benzinga.com/news/earnings/24/07/40037468/why-gillette-parent-procter-gamble-shares-are-tumbling-today" rel="noreferrer noopener"> $7.05&nbsp;(vs. consensus of $6.97)</a>.
P&amp;G reaffirmed its outlook for adjusted free cash flow productivity of&nbsp;90%, payment of around&nbsp;$10 billion in dividends and repurchasing&nbsp;$6 billion to&nbsp;$7 billion of common shares in fiscal 2025.
Investors can gain exposure to the stock via&nbsp;iShares U.S. Consumer Staples ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IYK#NYSE">IYK</a>) and Fidelity MSCI COnsumer Staples Index ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FSTA#NYSE">FSTA</a>).
Price Action: PG shares are down 0.81% at $170.88 premarket at the last check Friday.
Photo via Shutterstock
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/10/41397178/procter-gamble-earnings-are-imminent-these-most-accurate-analysts-revise-forecasts-ahead-of-earning" target="_blank" rel="noreferrer noopener">Procter &amp; Gamble Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call</a></li>
</ul>

Earnings

Equities

Large Cap

News

Guidance

Dividends

Buybacks

Movers

FSTA

iShares Trust Dow Jones USnsumer Goods Sector Index Fund

Procter & Gamble's Mixed Bag Q1: EPS Exceeds Estimates, Reaffirms Growth Outlook & More

Macquarie analyst Tim Nollen maintains Netflix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>) with a Outperform and maintains $795 price target.

Price Target

Analyst Ratings

NFLX

Macquarie Maintains Outperform on Netflix, Maintains $795 Price Target

Biotech

General

ARQT

Arcutis Gains Health Canada Approval For ZORYVE Foam 0.3% To Treat Seborrheic Dermatitis In Patients Aged 9 And Older; Marks First New Mechanism Topical Treatment For Condition In Canada In Over 20 Years

Susquehanna analyst Biju Perincheril maintains Occidental Petroleum (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OXY#NYSE">OXY</a>) with a Positive and lowers the price target from $78 to $77.

Susquehanna Maintains Positive on Occidental Petroleum, Lowers Price Target to $77

~10% Shareholder Believes Proposed Sale Represents an Egregious "Take Under" and Significantly Undervalues the Company
Urges the Board to Consider Shareholders' Best Interests and Disclose the Company's 2025 Projections so Investors Can Accurately Value the Company Against the Deal Price
Bradley L. Radoff, who collectively with his affiliates owns approximately 9.9% of the outstanding shares of GSE Systems, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GVP#NASDAQ">GVP</a>) ("GSE" or the "Company"), today sent the below letter to GSE Systems' Board of Directors (the "Board") indicating its opposition to the proposed take-private merger with Pelican Energy Partners ("Pelican").
&#x2A;&#x2A;&#x2A;
GSE Systems, Inc. 6940 Columbia Gateway Drive, Suite 470 Columbia, MD 21046 Attention: The Board of Directors
October 18, 2024
Members of the Board,
I am one of GSE's largest shareholders, with an approximately 9.9% stake in the Company. After reviewing the Company's belated and limited disclosures, I believe the proposed sale to Pelican significantly undervalues the Company and puts leadership's interests ahead of shareholders' best interests.
The Board, which collectively has limited public company experience and de minimis share ownership, appears to have allowed the Company to develop liquidity issues that have become the basis for what is seemingly a fire sale. Now, with this deal, the Board is seemingly doubling down on its missteps by giving up on the Company right as the nuclear power industry is entering a renaissance that should be a significant tailwind for GSE and its prospects for enhanced value creation.
Despite GSE's apparent runway for improved financial performance, you have refused to provide a view on the business for 2025. As a result, shareholders are unable to appropriately analyze the Company's prospects and evaluate a standalone future relative to the current deal. The Board's contention that it cannot provide projections because management's forecasts have historically been unreliable simply serves as an acknowledgment of your failures when it comes to governing the business and overseeing the executive leadership you put in place.
With respect to your decision to deprive shareholders of relevant information, it is highly unusual that the Company's definitive proxy statement for the merger did not contain forward-looking business projections. I appear to be one of the many shareholders who are disappointed with this insufficient disclosure. The Company's Form-8-K filed on October 8th, 2024 – just two weeks prior to the shareholder vote – was purportedly only put out in response to "demand letters alleging similar deficiencies and/or omissions regarding the disclosures made in the Preliminary Proxy Statement or the Definitive Proxy Statement."1
In the October 8th 8-K, GSE provided a mere glimpse of very encouraging and positive projections that implied more than $0.30 of quarterly earnings for a Company that currently trades at around $4. The projections, while incomplete, appear to show that the Company is beginning to materially benefit from the nuclear resurgence. Given this context, I am calling on you to provide the market with customary disclosures regarding the Company's forward-looking projections so shareholders can make the most informed decision on the transaction. If the Company continues to provide such limited disclosures as it did in the October 8th 8-K, then it should at least reset the record date for the Pelican merger to enable the investment community to sufficiently digest this new, albeit limited, information.
While the Company's legal counsel and bankers – who stand to make millions if the deal goes through – may have signed off on the disclosures to this point, the Board should know that this deal fails the smell test. Nothing in the merger agreement prevents you from providing more information and transparency to shareholders. I believe your decision to effectively keep GSE shareholders in the dark will define your directorship at GSE and be a black mark for any of you who intend to pursue other director opportunities. Shareholders have long memories.
While you have trumpeted Institutional Shareholder Services' recent report as an endorsement, I don't believe shareholders should give it any credence. The report neglects to mention the lack of initial projections, the magnitude of the late projections and the recent trading activity indicating that shareholders believe there is more value than is being offered by Pelican. In fact, approximately 30% of the Company's outstanding shares have traded at or above the deal price this week.
In closing, I believe an independent GSE has significant upside potential. The Board failed to provide projections prior to the record date and then reluctantly offered limited disclosure just two weeks prior to the shareholder meeting. This set of circumstances, combined with a comical fairness opinion and egregious transaction expenses, are very troubling. I once again demand normal course forward projections so that shareholders, who are the owners of the business, can fairly evaluate the Pelican transaction.
Sincerely,
Bradley L. Radoff

Management

~10% Shareholder Bradley L. Radoff Issues Open Letter To GSE Systems' Board Of Directors To State Opposition To Proposed Sale To Pelican Energy Partners; Believes Proposed Sale Represents An Egregious "Take Under" And Significantly Undervalues The Company

Susquehanna analyst Biju Perincheril maintains Hess (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HES#NYSE">HES</a>) with a Neutral and raises the price target from $149 to $154.

Susquehanna Maintains Neutral on Hess, Raises Price Target to $154

Rosenblatt analyst Barton Crockett maintains Netflix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>) with a Neutral and raises the price target from $635 to $680.

Rosenblatt Maintains Neutral on Netflix, Raises Price Target to $680

Cantor Fitzgerald analyst Josh Schimmer reiterates Zura Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZURA#NASDAQ">ZURA</a>) with a Overweight.

Reiteration

ZURA

Cantor Fitzgerald Reiterates Overweight on Zura Bio

As of Oct. 18, 2024, two stocks in the communication services sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the <a href="https://www.benzinga.com/topic/rsi">RSI is above 70</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>. 
Here's the latest list of major overbought players in this sector.
<h3 class="wp-block-heading">T-Mobile Us Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TMUS#NASDAQ">TMUS</a>)</h3>
<ul>
<li>T-Mobile announced redemption of Sprint 7.625% notes due Feb. 15, 2025. The company's stock gained around 13% over the past month and has a <a href="https://www.benzinga.com/quote/TMUS">52-week high of $222.73</a>.</li>
<li>RSI Value: 82.35&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
<li>TMUS Price Action: Shares of T-Mobile Us gained 1% to close at $221.95 on Thursday.</li>
</ul>
<h3 class="wp-block-heading">Sify Technologies Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SIFY#NASDAQ">SIFY</a>)</h3>
<ul>
<li>Sify Technologies will announce financial results for the second quarter on Tuesday, Oct. 22. The company's stock gained around 54% over the past month and <a href="https://www.benzinga.com/quote/SIFY">has a 52-week high</a> of $12.30.</li>
<li>RSI Value: 70.98</li>
<li>SIFY Price Action: Shares of Sify rose 14.8% to close at $3.73 on Thursday. </li>
</ul>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/10/41379749/abbvie-is-doing-very-well-but-jim-cramers-favorite-abbott-laboratories">AbbVie Is Doing &#8216;Very Well&#8217; But Jim Cramer&#8217;s Favorite? Abbott Laboratories</a></li>
</ul>

Short Ideas

Pre-Market Outlook

Markets

Trading Ideas

SIFY

TMUS

Top 2 Tech And Telecom Stocks That May Crash In Q4

Susquehanna analyst Biju Perincheril maintains Diamondback Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FANG#NASDAQ">FANG</a>) with a Positive and lowers the price target from $237 to $233.

FANG

Susquehanna Maintains Positive on Diamondback Energy, Lowers Price Target to $233

One step closer to achieving public reimbursement of AMVUTTRA&#xAE; for hATTR patients in Canada
MISSISSAUGA, ON, Oct. 18, 2024 /CNW/ - Alnylam Canada ULC is pleased to announce that it has signed a Letter of Intent (LOI) with the pan-Canadian Pharmaceutical Alliance (pCPA) for the public reimbursement of AMVUTTRA&#xAE; (vutrisiran injection), an RNAi therapeutic administered by quarterly subcutaneous injection, for the treatment of stage 1 or stage 2 polyneuropathy in adult patients with hereditary transthyretin-mediated amyloidosis (hATTR amyloidosis).1&nbsp;This comes following a positive recommendation from the Canadian Drug Agency (CDA) and the Institut national d'excellence en santé et services sociaux (INESSS), and signals the next step in the process where individual participating provinces and territories will start to list&nbsp;AMVUTTRA&#xAE; on their formularies.

Global

ALNY

Alnylam Canada Signs LOI From Pan-Canadian Pharmaceutical Alliance For The Public Reimbursement Of AMVUTTRA For The Treatment Of Hereditary Transthyretin-Mediated Amyloidosis In Adults

Susquehanna analyst Biju Perincheril maintains Devon Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DVN#NYSE">DVN</a>) with a Positive and lowers the price target from $63 to $62.

Susquehanna Maintains Positive on Devon Energy, Lowers Price Target to $62

Telsey Advisory Group analyst Dana Telsey maintains Deckers Outdoor (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DECK#NYSE">DECK</a>) with a Outperform, adjusts target to $183 from $183 (forward stock split 6:1).

DECK

Telsey Advisory Group Maintains Outperform on Deckers Outdoor, Adjusts Price Target To $183 (forward stock split 6:1)

Susquehanna analyst Biju Perincheril maintains ConocoPhillips (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COP#NYSE">COP</a>) with a Positive and lowers the price target from $147 to $144.

Susquehanna Maintains Positive on ConocoPhillips, Lowers Price Target to $144

Cantor Fitzgerald analyst Andres Sheppard initiates coverage on PureCycle Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCT#NASDAQ">PCT</a>) with a Overweight rating and announces Price Target of $14.

Initiation

Cantor Fitzgerald Initiates Coverage On PureCycle Technologies with Overweight Rating, Announces Price Target of $14

<a href="https://www.aljazeera.com/news/liveblog/2024/10/18/live-israel-says-hamas-chief-yahya-sinwar-killed-war-on-gaza-to-continue" title="https://www.aljazeera.com/news/liveblog/2024/10/18/live-israel-says-hamas-chief-yahya-sinwar-killed-war-on-gaza-to-continue">https://www.aljazeera.com/news/liveblog/2024/10/18/live-israel-says-hamas-chief-yahya-sinwar-killed-war-on-gaza-to-continue</a>

Macro Economic Events

Economics

iShares MSCI Israel Capped Investable Market Index Fund

ISRA

Hamas Senior Official Al-Hayya Says Group Is Continuing Path Until Achieving Palestinian People's Ambitions; Says Sinwar's Death Will Turn Into A Curse On 'The Occupiers'; Sinwar's Death Will Only Strengthen The Group; Israeli Hostages Will Not Return Until Aggression On Gaza Stops And Withdrawal Of Israeli Forces

Susquehanna analyst Biju Perincheril maintains APA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APA#NASDAQ">APA</a>) with a Positive and lowers the price target from $52 to $48.

Susquehanna Maintains Positive on APA, Lowers Price Target to $48

WIIM

DRUG

Bright Minds Biosciences shares are trading higher. The company announced a $35 million non-brokered private placement.

<h3>Gainers</h3>
<ul>
<li>Lion Group Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LGHL#NASDAQ">LGHL</a>) shares rose 29.8% to $0.27 during Friday's pre-market session. The company's market cap stands at $1.8 million. </li>
<li>Prestige Wealth (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PWM#NASDAQ">PWM</a>) stock moved upwards by 12.49% to $0.9. The market value of their outstanding shares is at $10.8 million. </li>
<li>UP Fintech Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TIGR#NASDAQ">TIGR</a>) stock moved upwards by 9.74% to $7.88. The market value of their outstanding shares is at $1.2 billion. </li>
<li>Yiren Digital (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YRD#NYSE">YRD</a>) stock increased by 9.54% to $6.08. The company's market cap stands at $528.5 million. </li>
<li>Garden Stage (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GSIW#NASDAQ">GSIW</a>) stock rose 7.23% to $1.63. The market value of their outstanding shares is at $25.4 million. </li>
<li>LexinFintech Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LX#NASDAQ">LX</a>) shares rose 7.01% to $3.05. The market value of their outstanding shares is at $501.4 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Pineapple Financial (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/PAPL#AMEX">PAPL</a>) shares declined by 8.3% to $0.66 during Friday's pre-market session. The company's market cap stands at $4.8 million. </li>
<li>Netcapital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NCPL#NASDAQ">NCPL</a>) shares declined by 5.15% to $1.66. The company's market cap stands at $1.2 million. </li>
<li>Santech Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STEC#NASDAQ">STEC</a>) stock declined by 4.89% to $1.51. The company's market cap stands at $42.3 million. </li>
<li>Western Alliance (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WAL#NYSE">WAL</a>) stock declined by 4.18% to $90.0. The company's market cap stands at $9.9 billion. The company's, Q3 earnings came out yesterday. </li>
<li>New York Community (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NYCB#NYSE">NYCB</a>) stock decreased by 4.12% to $11.87. The market value of their outstanding shares is at $4.9 billion. </li>
<li>MicroSectors FANG Index -3X Inverse Leveraged ETNs due January 8, 2038 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FNGD#NYSE">FNGD</a>) stock decreased by 3.62% to $19.47. 
See Also: <a href="http://www.benzinga.com/money/best-financial-services-stocks/" title="www.benzinga.com/money/best-financial-services-stocks/">www.benzinga.com/money/best-financial-services-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

FNGD

GSIW

LGHL

NCPL

NYCB

PAPL

STEC

TIGR

12 Financials Stocks Moving In Friday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>Catheter Precision (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/VTAK#AMEX">VTAK</a>) stock increased by 151.9% to $1.11 during Friday's pre-market session. The company's market cap stands at $3.1 million. </li>
<li>Akanda (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AKAN#NASDAQ">AKAN</a>) stock rose 71.13% to $1.66. The company's market cap stands at $4.7 million. </li>
<li>Tenon Medical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TNON#NASDAQ">TNON</a>) shares increased by 39.06% to $4.77. The company's market cap stands at $2.6 million. </li>
<li>cbdMD (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/YCBD#AMEX">YCBD</a>) stock moved upwards by 21.83% to $0.52. The company's market cap stands at $1.9 million. </li>
<li>Tevogen Bio Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TVGN#NASDAQ">TVGN</a>) stock increased by 21.01% to $1.67. The market value of their outstanding shares is at $284.9 million. </li>
<li>Carmell (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTCX#NASDAQ">CTCX</a>) shares increased by 10.77% to $0.53. The market value of their outstanding shares is at $11.1 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Orgenesis (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ORGS#NASDAQ">ORGS</a>) shares declined by 37.9% to $2.01 during Friday's pre-market session. The market value of their outstanding shares is at $9.5 million. </li>
<li>Molecular Templates (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTEM#NASDAQ">MTEM</a>) shares decreased by 30.11% to $0.65. The company's market cap stands at $4.2 million. </li>
<li>NKGen Biotech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NKGN#NASDAQ">NKGN</a>) shares declined by 29.02% to $0.5. The company's market cap stands at $17.5 million. </li>
<li>Chromocell Therapeutics (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/CHRO#AMEX">CHRO</a>) shares fell 12.81% to $0.67. The company's market cap stands at $3.8 million. </li>
<li>Kazia Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KZIA#NASDAQ">KZIA</a>) shares decreased by 12.68% to $0.46. The market value of their outstanding shares is at $13.7 million. </li>
<li>Hepion Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HEPA#NASDAQ">HEPA</a>) shares declined by 11.91% to $0.66. The market value of their outstanding shares is at $3.8 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AKAN

CHRO

CTCX

HEPA

KZIA

MTEM

NKGN

ORGS

TNON

TVGN

VTAK

YCBD

12 Health Care Stocks Moving In Friday's Pre-Market Session

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
PermRock Royalty Trust (NYSE:<a href="https://investorplace.com/stock-quotes/prt-stock-quote/">PRT</a>) just reported results for the first quarter of 2024.<ul><li>PermRock Royalty Trust reported earnings per share of 9.2 cents.</li><li>The company reported revenue of $1.31 million.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/earning-results/2024/05/prt-stock-earnings-permrock-royalty-trust-for-q1-of-2024/">PRT Stock Earnings: PermRock Royalty Trust Reported Results for Q1 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

PRT Stock Earnings: PermRock Royalty Trust Reported Results for Q1 2024

This week, several dividend stocks are trading close to their 52-week lows. Here is a list of ten such stocks that are also reaching their ex-divid...

Ex-Dividend Date Nearing for These 10 Stocks

Ex-Dividend Date Nearing for These 10 Stocks- Week of May 27, 2024

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Whether you&rsquo;re an income investor in retirement seeking a steady source of income or a younger investor who is looking to build a strong portfolio and reinvest your dividend payouts, you should really consider monthly <a href="https://investorplace.com/stock-types/dividend-stocks/">dividend stocks</a>.



These stocks have a lot of benefits. They provide the appeal of regular income with a steady cash flow that can supplement your retirement income and help pay for living expenses. 



Or the frequent payouts are a steady source that can be reinvested into the market to compound your investments and accelerate portfolio growth.



While not every dividend stock offers a monthly dividend, it pays to look for those that make it a regular practice. 



There are several types of companies, such as real estate investment trusts and business development corporations, that have unique tax structures that make it advantageous for them to offer a monthly dividend. 



Other companies do it because it Companies opt to pay monthly dividends for several reasons. Firstly, it attracts a broader base of investors, which can improve stock liquidity and stability.



We&rsquo;ll use the Dividend Grader to look for the best monthly dividend stocks that you can buy, based on factors such as dividend yield and consistency, earnings performance, growth and analyst sentiment. 



If you want to see a regular flow of income into your portfolio, these are the monthly dividend stocks to consider.



<h2>Modiv Industrial&nbsp;(MDV)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/07/dividends-payment-300x169.jpg" alt='sheet of paper marked "dividends" with a $20 bill on top of it to represent dividend stocks'><div>Source: Shutterstock</div></div>Real estate investment trust Modiv Industrial (NYSE:<a href="https://investorplace.com/stock-quotes/mdv-stock-quote/">MDV</a>) invests in industrial manufacturing facilities. Altogether, it has ownership of more than 40 properties in 16 U.S. states.



REITs are one of the most popular monthly dividend stocks because they come with significant tax benefits. Because they distribute at least 90% of their taxable income, REITs aren&rsquo;t subject to corporate income taxes.



Modiv bought more than $214 million in industrial assets in 2023, and plans to continue buying this year.



Earnings for the first quarter included $11.9 million in rental income, up $1.6 million from a year ago. The most compelling thing about Modiv is its fascinatingly descriptive earnings reports. No other company uses <a href="https://modiv.com/modiv-industrial-announces-first-quarter-2024-results/">language like this</a>:



&ldquo;Like a sniper laying prone for a seemingly endless period of time, scanning for the right target and adjusting for the wind, before they find their shot, we too have been ever so patient in our acquisitions process over the past six plus months as we waited to pull the trigger on the right transaction.&rdquo;



MDV stock has a dividend yield of 7.6% and the stock is up 9% this year. It gets a &ldquo;B&rdquo; rating in the Dividend Grader.



<h2>Main Street Capital (MAIN)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/07/dividends-300x169.jpg" alt="7 Winning High-Yield Dividend Stocks With Payouts Over 5%"><div>Source: Shutterstock</div></div>Main Street Capital (NYSE:<a href="https://investorplace.com/stock-quotes/main-stock-quote/">MAIN</a>) is an equity firm. With more than 200 investments in its history, the company focuses on putting its money into lower and middle market companies.



It&rsquo;s an active investor &mdash; on <a href="https://www.mainstcapital.com/investors/news-events/press-releases/detail/2685/main-street-announces-new-portfolio-investment">May 30</a>, it announced $32.8 million for an unnamed company that provides supply chain management services for federal government agencies. 



On <a href="https://www.mainstcapital.com/investors/news-events/press-releases/detail/2686/main-street-announces-new-portfolio-investment-and-partial">June 11</a>, it announced it completed a $36.9 million investment to facilitate the management-led buyout out Nello Industries, which makes utility poles and towers.



<a href="https://www.mainstcapital.com/investors/news-events/press-releases/detail/2682/main-street-announces-first-quarter-2024-results">Earnings for the first quarter</a> were $131.6 million in investment income, up from $120 million a year ago. The company attributed much of the increase to a boost in interest income from higher interest rates.



MAIN stock is up 13% so far this year and pays a dividend yield of 8.4%. It gets an &ldquo;A&rdquo; rating in the Dividend Grader.



<h2>PennantPark Floating Rate Capital (PFLT)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/07/dividends-jar-300x169.jpg" alt='Glass jar of coins marked "dividends" to represent dividend stocks. dividend stocks for passive income'><div>Source: Shutterstock</div></div>PennantPark Floating Rate Capital (NYSE:<a href="https://investorplace.com/stock-quotes/pflt-stock-quote/">PFLT</a>) is structured as a business development company, or BDC. Like REITs, BDCs distribute 90% of their income to shareholders, making them a prized stock for anyone who wants monthly dividend income.



PennantPark&rsquo;s primarily invests in middle market companies with first-lien debt, so the debts are guaranteed with collateral that PennantPark can take should a company default on its loan.



The company maintains an investment portfolio of $1.47 billion with net assets of $720 million. 



In the first quarter, PennantPark received $19.1 million investment income and paid out 31 cents per share in dividends, versus a year ago when it had $13.7 million in investment income and paid out 28.5 cents per share in dividends.



PFLT stock is down 6% this year but it pays a hefty 10.8% dividend yield, which means it gets a &ldquo;B&rdquo; rating in the Dividend Grader.



<h2>Oxford Square Capital (OXSQ)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/07/dividends-letters-300x169.jpg" alt="dividend stocks"><div>Source: Shutterstock</div></div>Oxford Square Capital&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/oxsq-stock-quote/">OXSQ</a>) is another BDC. This one is headquartered in Greenwich, Connecticut and invests in corporate debt securities and collateralized loan obligation structured investments that own corporate debt securities.



Collateralized loan obligations, or CLOs, are security backed by a pool of debt. Oxford Square gets debt payments from the underlying loans of the CLO and assumes the risk should borrowers default.



<a href="https://ir.oxfordsquarecapital.com/news-market-data/press-releases/news-details/2024/Oxford-Square-Capital-Corp.-Announces-Net-Asset-Value-and-Selected-Financial-Results-for-the-Quarter-Ended-March-31-2024-and-Declaration-of-Distributions-on-Common-Stock-for-the-Months-Ending-July-31-August-31-and-September-30-2024/default.aspx">Earnings for the first quarter</a> were $10.7 million in investment income, down from $12.3 million in the first quarter of 2023. It made new investments of $12.1 million in the quarter and received $19.3 million from sales and repayments of investments.



Oxford Square is a small company that packs a huge dividend punch. Despite having a market cap of only $180 million, the company pays a dividend yield of nearly 14%. 



The stock is up 6% this year and gets a &ldquo;B&rdquo; rating in the Dividend Grader.



<h2>Gladstone Investment Corp.&nbsp;(GAIN)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/07/dividends-tickers-300x169.jpg" alt='A stock market ticker tape projects the word "DIVIDENDS" in white text. representing dividend stocks to buy'><div>Source: Shutterstock</div></div>Another BDC on our list is Gladstone Investment Corp.&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/gain-stock-quote/">GAIN</a>). This business development company invests in mature lower middle market companies, targeting businesses with earnings before interest, taxes, depreciation, and amortization of $4 million to $15 million.



The company is currently&nbsp;<a href="https://www.gladstoneinvestment.com/portfolio/current-investment-portfolio">investing</a>&nbsp;in 24 businesses across the country, including manufacturers, consumer products companies and business services. Its clients include plumbers, education companies, contractors and fabrication companies.



In the fourth quarter of its fiscal 2023 year (ending March 31, 2024), Gladstone earned $23.6 million in total investment income versus $23 million in the same quarter a year ago. 



However, expenses increased by nearly $5 million in the quarter, bringing net investment income down to $5.3 million versus $9.7 million a year ago.



The company realized a $14.7 million loss in the quarter in its investment in The Mountain Corp., which liquidated and dissolved.



Despite that setback, the stock is in fine shape. GAIN stock is up 13% this year and it pays a dividend yield of 8.4%. That gives it a &ldquo;B&rdquo; rating in the Dividend Grader.



<h2>SL Green Realty (SLG)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/07/SLG1600-300x169.jpg" alt="A magnifying glass zooms in on the website for SL Green Realty Corp (SLG)."><div>Source: Shutterstock</div></div>SL Green Realty (NYSE:<a href="https://investorplace.com/stock-quotes/slg-stock-quote/">SLG</a>) calls itself the largest commercial landlord in New York City. 



The company focuses on commercial properties in Manhattan, with interests in 57 buildings that total 32.4 million square feet.



Recent activity includes a <a href="https://slgreen.com/sl-green-signs-leases-totaling-104000-square-feet-at-one-madison-avenue/">1.4 million square-foot office tower</a> at One Madison Avenue, where three new tenants signed in April for more than 104,000 square feet of space. 



The company also <a href="https://slgreen.com/sl-green-and-vornado-announce-280-park-avenue-mortgage-loan-refinancing/">announced</a> a refinancing with Vornado Realty Trust (NYSE:<a href="https://investorplace.com/stock-quotes/vno-stock-quote/">VNO</a>) for a $1.07 billion secured mortgage at 280 Park Ave. in Manhattan.



<a href="https://slgreen.com/sl-green-realty-corp-reports-first-quarter-2024-eps-of-0-20-per-share-and-ffo-of-3-07-per-share/">Rental revenue</a> in the first quarter was $128.2 million, down from $174.5 million a year ago. Total revenue was $187.8 million, down from $245 million.



However, the company&rsquo;s total net income of $13.1 million and 20 cents per share was a vast improvement from a year ago, when SL Green posted a loss of $39.7 million and 63 cents per share.



SLG stock is up 25% this year and pays a dividend yield of 5.8%. It gets a &ldquo;B&rdquo; rating in the Dividend Grader.



<h2>PermRock Royalty Trust (PRT)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/08/dividend-stocks-to-buy-300x169.jpg" alt='dividend stocks: A calculator projecting the word "DIVIDEND" rests on a pile of gold and silver coins.'><div>Source: Shutterstock</div></div>PermRock Royalty Trust (NYSE:<a href="https://investorplace.com/stock-quotes/prt-stock-quote/">PRT</a>) is another type of business structure that can often be found in monthly dividend stocks. 



A royalty trust owns natural resource rights, including oil, gas, and minerals. It distributes income from the sale of those resources in the form of dividends to its shareholders.



Permrock has the rights to assets of Boaz Energy, which pays 80% of net profits interest from the company&rsquo;s oil and gas holdings in the Permian Basin of west Texas.



In its most recent distribution, Permrock sold 26,162 barrels of oil for an average price of $78.88 per barrel in May versus 23,156 barrels in April at an average price of $74.64.



Total payouts for the month were $490,223, or 4.02 cents per trust unit. That doesn&rsquo;t sound like a lot, but overall the company has a strong payout of 11.3%.



PRT stock is down 14% this year but it gets a &ldquo;B&rdquo; rating in the Dividend Grader.



On the date of publication, neither Louis&nbsp;Navellier nor the InvestorPlace Research Staff member primarily responsible for this article held (either directly or indirectly) any positions in the securities mentioned in this article.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	
The post <a href="https://investorplace.com/market360/2024/06/7-monthly-dividend-stocks-for-your-june-must-buy-list/">7 Monthly Dividend Stocks for Your June Must-Buy List</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

7 Monthly Dividend Stocks for Your June Must-Buy List

PermRock Royalty Trust declares $0.04 dividend

Ex-Dividend Date Nearing for These 10 Stocks – Week of June 24, 2024

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
PermRock Royalty Trust (NYSE:<a href="https://investorplace.com/stock-quotes/prt-stock-quote/">PRT</a>) just reported results for the second quarter of 2024.<ul><li>PermRock Royalty Trust reported earnings per share of 11 cents.</li><li>The company reported revenue of $1.67 million.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/earning-results/2024/08/prt-stock-earnings-permrock-royalty-trust-for-q2-of-2024/">PRT Stock Earnings: PermRock Royalty Trust Reported Results for Q2 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

PRT Stock Earnings: PermRock Royalty Trust Reported Results for Q2 2024

PermRock Royalty Trust declares $0.03 dividend

ARCO

BGFV

FGBI

GAIN

KREF

LCII

MAIN

MARPS

MBCN

MVBF

OFLX

OXSQ

PFLT

PINC

PKST

PRGO

XRAY

Commodities

Press Releases

PermRock Royalty Trust Declares Monthly Cash Distribution

Amplify Energy

Battalion Oil

BP Prudhoe Bay Royalty Trust Common Stock

BP Prudhoe Bay

Barnwell Industries

Cross Timbers Royalty

Empire Petroleum Corporation Common Stock

Empire Petroleum

Evolution Petroleum Corporation, Inc. Common Stock

Evolution Petroleum

Gran Tierra Energy

Houston American Energy Corporation Common Stock

Houston American Energy

Indonesia Energy Corporation Limited Ordinary Shares

Indonesia Energy Corp

Marine Petroleum Trust - Units of Beneficial Interest

Marine Petroleum Tr

Mesa Royalty

MV Oil Trust Units of Beneficial Interests

MV Oil

Mexco Energy

North European Oil Royality Trust Common Stock

North European Oil

PEDEVCO

PHX Minerals

Permianville Royalty

San Juan Basin Royalty Trust Common Stock

San Juan Basin Royalty

Trio Petroleum

US Energy

VOC Energy Trust Units of Beneficial Interest

Comments

PermRock Royalty Trust

Vendite allo scoperto

PermRock Royalty Trust (NYSE:PRT) Azioni, Report sulle vendite allo scoperto

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO